1. Evaluation of the Effectiveness of Metabolites of Bacterial Strains Bacillus thuringiensis against Human Influenza Virus A/Aichi/2/68 (H3N2) In Vitro and In Vivo
- Author
-
A I Zakabunin, N. A. Mazurkova, I. S. Andreeva, Ekaterina Filippova, A. S. Safatov, and L. I. Puchkova
- Subjects
human influenza virus ,0301 basic medicine ,Kobuvirus ,Human influenza ,Bacillus thuringiensis ,Biology ,Antiviral Agents ,Article ,General Biochemistry, Genetics and Molecular Biology ,Virus ,Microbiology ,03 medical and health sciences ,Oseltamivir ,0302 clinical medicine ,Virus strain ,In vivo ,Influenza, Human ,Humans ,chemistry.chemical_classification ,Influenza A Virus, H3N2 Subtype ,virus diseases ,General Medicine ,Reference drug ,biology.organism_classification ,In vitro ,030104 developmental biology ,Enzyme ,chemistry ,Influenza A virus ,antiviral activity ,030217 neurology & neurosurgery - Abstract
The morphological and physiological characteristics of Bacillus thuringiensis strains were analyzed and conditions for obtaining culture fluid with maximum yield of secreted RNases were determined. Zymographic analysis showed that culture fluid of B. thuringiensis strains along with low-molecular-weight (15-20 kDa) RNases contained enzymes with a molecular weight ~55 kDa and their content depended on the duration and conditions of culturing. Preparations based on B. thuringiensis culture fluid were effective against human influenza virus A/Aichi/2/68 (H3N2). In experiments on mice infected with 10 LD50 influenza virus strain A/Aichi/2/68 (H3N2), we selected effective variants of preparations based on culture fluid of B. thuringiensi strains for preventive administration that provided reliable protection of infected animals (protection coefficient 50%), close to that of the reference drug Tamiflu.
- Published
- 2020
- Full Text
- View/download PDF